Morgan Stanley analyst Ronald Kamdem raised the firm’s price target on American Healthcare REIT (AHR) to $52 from $48 and keeps an Overweight rating on the shares after update the firm’s FY25 and FY26 FFO per share estimates to reflect Q3 earnings.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AHR:
- American Healthcare REIT price target raised to $60 from $51 at BofA
- American Healthcare REIT price target raised to $56 from $51 at UBS
- American Healthcare REIT price target raised to $55 from $47 at Scotiabank
- American Healthcare REIT price target raised to $55 from $43 at KeyBanc
- American Healthcare REIT price target raised to $54 from $45 at RBC Capital